148 related articles for article (PubMed ID: 31241209)
1. Overexpression of HPIP as a biomarker for metastasis and prognosis prediction in endometrial cancer patients.
Cheng L; Zhao T; Li S; Wang Y; Fei H; Meng F
J Clin Lab Anal; 2019 Oct; 33(8):e22959. PubMed ID: 31241209
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinicopathological significance of hematopoietic pre-B cell leukemia transcription factor-interacting protein in cervical carcinoma.
Wang Y; Li D; Liu Y; Tian S; Chen X
Pathol Res Pract; 2018 Sep; 214(9):1340-1344. PubMed ID: 30033330
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of HPIP and the associated prognosis in cervical cancer.
Meng F; Liu H; Liu S; Ma R
Oncotarget; 2017 Sep; 8(41):70262-70270. PubMed ID: 29050277
[TBL] [Abstract][Full Text] [Related]
4. HPIP expression predicts chemoresistance and poor clinical outcomes in patients with epithelial ovarian cancer.
Wang Y; Li M; Meng F; Lou G
Hum Pathol; 2017 Feb; 60():114-120. PubMed ID: 27818289
[TBL] [Abstract][Full Text] [Related]
5. Expression of HPIP in epithelial ovarian carcinoma: a clinicopathological study.
Wang Y; Meng F; Liu Y; Chen X
Onco Targets Ther; 2017; 10():95-100. PubMed ID: 28053543
[TBL] [Abstract][Full Text] [Related]
6. RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
Liu S; Lin M; Ji H; Ding J; Zhu J; Ma R; Meng F
Diagn Pathol; 2019 Jan; 14(1):7. PubMed ID: 30684972
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of special AT-rich sequence-binding protein 1 in endometrial cancer: a clinicopathologic study.
Zhang Y; Wang L; Liu Y; Meng F; Wang S; Shang P; Gao Y; Chen X
Int J Gynecol Cancer; 2015 Jan; 25(1):4-11. PubMed ID: 25347096
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of MMSET in endometrial cancer: a clinicopathologic study.
Xiao M; Yang S; Chen J; Ning X; Guo L; Huang K; Sui L
J Surg Oncol; 2013 Mar; 107(4):428-32. PubMed ID: 22886632
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Lysine-Specific Demethylase 1 Is Associated With Tumor Progression and Unfavorable Prognosis in Chinese Patients With Endometrioid Endometrial Adenocarcinoma.
Liu YD; Dai M; Yang SS; Xiao M; Meng FL; Chen XW
Int J Gynecol Cancer; 2015 Oct; 25(8):1453-60. PubMed ID: 26166558
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Wnt7a is associated with tumor progression and unfavorable prognosis in endometrial cancer.
Liu Y; Meng F; Xu Y; Yang S; Xiao M; Chen X; Lou G
Int J Gynecol Cancer; 2013 Feb; 23(2):304-11. PubMed ID: 23321718
[TBL] [Abstract][Full Text] [Related]
11. Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its clinical significance.
Hu Y; Yu L; Xia F; Liang F; Cheng C; Huang Y; Xiao L
Clin Transl Oncol; 2021 Aug; 23(8):1711-1716. PubMed ID: 33635467
[TBL] [Abstract][Full Text] [Related]
12. High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome.
Li P; Yin H; Meng F; Liu S; Liu H; Ma R
Pathol Res Pract; 2018 May; 214(5):727-731. PubMed ID: 29526558
[TBL] [Abstract][Full Text] [Related]
13. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
14. HPIP: a predictor of lymph node metastasis and poor survival in cervical cancer.
Cao S; Sun J; Lin S; Zhao L; Wu D; Liang T; Sheng W
Onco Targets Ther; 2017; 10():4205-4211. PubMed ID: 28894377
[TBL] [Abstract][Full Text] [Related]
15. Upregulated delta-like protein 3 expression is a diagnostic and prognostic marker in endometrial cancer: A retrospective study.
Wang J; Zhang K; Liu Z; Wang T; Shi F; Zhang Y; Su J; Jia Y
Medicine (Baltimore); 2018 Dec; 97(51):e13442. PubMed ID: 30572444
[TBL] [Abstract][Full Text] [Related]
16. Expressions and clinical significance of COX-2, VEGF-C, and EFGR in endometrial carcinoma.
Cai S; Zhang YX; Han K; Ding YQ
Arch Gynecol Obstet; 2017 Jul; 296(1):93-98. PubMed ID: 28474124
[TBL] [Abstract][Full Text] [Related]
17. Two decades of a protooncogene HPIP/PBXIP1: Uncovering the tale from germ cell to cancer.
Khumukcham SS; Manavathi B
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188576. PubMed ID: 34090932
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis.
Shang P; Meng F; Liu Y; Chen X
Tumour Biol; 2015 Jun; 36(6):4479-85. PubMed ID: 25934333
[TBL] [Abstract][Full Text] [Related]
19. Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients.
Zhang Y; Hua W; Niu LC; Li SM; Wang YM; Shang L; Zhang C; Li WN; Wang R; Chen BL; Xin XY; Zhang YQ; Wang J
Tumour Biol; 2016 Jul; 37(7):9423-31. PubMed ID: 26781874
[TBL] [Abstract][Full Text] [Related]
20. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
